Publisher's Synopsis
The highest rates of gastric cancer are observed in eastern Asia, South America and eastern Europe. More than half of all cases worldwide occur in eastern Asia. Distinguished experts in Asia have reviewed current topics and future perspectives for gastric cancer treatment in molecular pathology, tissue engineering, surgery and chemotherapy. Advances in diagnosis and treatment offer excellent long-term survival rates in the case of early cancer diagnosis, but the prognosis of advanced cancer still remains poor. A detailed understanding of molecular pathogenesis and the individual characteristics of gastric cancer and the development of new medical technologies and therapeutic agents help to provide personalized cancer care for patients of early and advanced cancer. For ongoing success, interactions and developments between bench and bedside as well as clinics and bench are crucial. This special issue is recommended for researchers, pathologists, surgeons, physicians and oncologists in the field of gastroenterology, who are interested in the current topics and future perspectives of molecular pathology, tissue engineering, surgery and chemotherapy of gastric cancer.
